Military Infectious Diseases Research Program

What Military Infectious Diseases Research Program does

The Military Infectious Diseases Research Program (MIDRP) is a subordinate component of the Defense Health Agency Research & Development – U.S. Army Medical Research and Development Command (DHA R&D-MRDC), a U.S. Department of Defense military research command headquartered at Fort Detrick, Maryland. DHA R&D-MRDC operates as a global biomedical research enterprise composed of multiple specialized institutes: USAMRIID (infectious diseases and bio-terror threat mitigation, including vaccines, therapeutics, and diagnostics for anthrax, Ebola, and Marburg), WRAIR (infectious diseases, brain health, and Soldier performance, contributor to nearly all FDA-approved antimalarials and leader of the world's largest HIV vaccine efficacy trial), USAISR (combat casualty care and battlefield injury innovations such as the SAM Junctional Tourniquet and cold-stored platelets), USAMRICD (chemical defense including bio-scavenger pretreatments and the naloxone auto-injector), USARIEM (environmental and extreme-conditions medicine, including the Six Cylinder Thermoregulatory Model and CoWEDA), USAARL (aeromedical and aviation Soldier safety), and CDMRP (congressionally directed medical research programs). MIDRP specifically focuses on mitigating the impact of infectious diseases on U.S. forces in large-scale combat operations.

The technical stack spans novel antibody discovery platforms, mRNA vaccine development, a pilot bioproduction facility, chemical defense countermeasures, environmental physiology modeling, and the FDA-cleared APPRAISE-HRI AI-enabled decision-support application for hemorrhage risk stratification. The organization maintains a global research footprint with direct reporting units positioned worldwide, supporting U.S. Warfighters, global combatant commands, and allied forces, with technology transfer to nonfederal parties through its Office of Research and Technology Applications.

The entity is a U.S. government military research command and does not operate on a commercial revenue model. All funding flows from Congressional appropriations and defense budgets via the Defense Health Agency and U.S. Army Medical Command chain. There are no venture capital investors, shareholders, or commercial pricing structures. The commanding general, currently Brigadier General Constance L. Jenkins (assumed command July 10, 2026), reports through standard military and DHA leadership channels.

Name

Military Infectious Diseases Research Program

Legal name

Defense Health Agency Research & Development - U.S. Army Medical Research and Development Command

Website

https://mrdc.health.mil

Company type

Private

Founded year

1777

Operating status

Operating

Short description

The Military Infectious Diseases Research Program is a U.S. Department of Defense research command, part of DHA R&D-MRDC, that develops vaccines, therapeutics, diagnostics, and medical countermeasures against infectious diseases and biological threats to protect U.S. Warfighters and allied forces.

Ownership category

akta.pro rank

Product category

Military Medical Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Biological Product (except Diagnostic) Manufacturing (325414), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Defense R&D, Test, Evaluation & Innovation (BPAIAHAC)

akta.pro secondary industries

Military & Veterans Public Health Departments (HLAJAAAI), Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC), Infectious Disease Specialty Pharmaceuticals (Non-vaccine) (HLAIACAM), Infectious Disease & Antimicrobials Pharmaceuticals (HLAIAAAG), Travel & Tropical Disease Vaccines (HLAIAEAE), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)

Keywords

• Military medical research
• Infectious disease research
• Vaccine development
• Combat casualty care
• Medical countermeasures

Headquarters

HQ city

Fort Detrick

HQ country

United States

HQ region

North America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Distribution channels3 records

Marketing channels4 records

Core offering

The Military Infectious Diseases Research Program conducts cutting-edge biomedical research to address unique challenges faced by U.S. Warfighters, including infectious disease research and bio-terror threat mitigation, combat casualty care, chemical defense countermeasures, environmental medicine, and aeromedical safety. It develops vaccines, monoclonal antibody therapeutics, diagnostics, medical devices, and decision-support tools deployable through Defense Health Agency channels and licensed to commercial partners via technology transfer.

Product overview

DHA R&D-MRDC (Defense Health Agency Research & Development - Medical Research and Development Command) is a comprehensive military medical research enterprise comprising multiple specialized research institutes. The portfolio includes USAMRIID (infectious diseases and bio-terror threat mitigation), WRAIR (infectious diseases, brain health, and Soldier performance), USAISR (combat casualty care), USAMRICD (chemical defense), USARIEM (environmental medicine), USAARL (aeromedical research), and CDMRP (congressionally directed medical research programs). Together, these institutes conduct cutting-edge biomedical research to address unique challenges faced by Warfighters, delivering solutions that enhance operational effectiveness and resilience.

Differentiator

Problem solved

Functional benefit

Products and services

• U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) The Department of War's premier institute for bio-terror threat mitigation and infectious disease research, developing vaccines, therapeutics, and diagnostics to combat deadly pathogens such as anthrax, Ebola, and Marburg virus. 用于支撑国防部和全球作战司令部的生物威胁防御需求。
• Walter Reed Army Institute of Research (WRAIR) The Department of War's largest and most diverse biomedical research institute, specializing in infectious diseases, brain health, and Soldier performance optimization, with global research network instrumental in discovery and development of nearly all FDA-approved antimalarial drugs.
• U.S. Army Institute of Surgical Research (USAISR) The world's leading institute for combat casualty care research, specializing in life-saving medical innovations for battlefield injuries including the SAM Junctional Tourniquet and cold-stored platelets research.
• U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) The Department of War's leading institute for medical chemical defense research, focused on protecting Warfighters from chemical threats including bio-scavenger pretreatments for nerve agent exposure and the Rapid Opioid Countermeasure System.
• U.S. Army Research Institute of Environmental Medicine (USARIEM) Conducts research to optimize Soldier health and performance in extreme environments including heat, cold, altitude, and physical exertion, developing tools such as the Individual Heat Optimization Training Tool and Cold Weather Ensemble Decision Aid.
• U.S. Army Aeromedical Research Laboratory (USAARL) Specializes in aviation Soldier safety and performance, conducting research on acoustics, vision, blast exposure, and aeromedical devices with its Environmental Sensors in Training program for wearable blast exposure monitoring.
• Congressionally Directed Medical Research Programs (CDMRP) Manages high-impact medical research initiatives addressing critical health challenges for military personnel and the general public, including cancer research, neurological and psychological health, infectious diseases, and military-relevant health concerns.

Quantifiable outcome

• Development of first FDA-cleared AI software for hemorrhage triage of combat casualties (APPRAISE-HRI)
• +5 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Ten partnerships are on record, tiered core and notable.

• U.S. Food and Drug AdministrationcoreStrategic or Co-development PartnerOngoing collaboration for regulatory approval of medical countermeasures, diagnostics, and AI-enabled healthcare tools developed by the research program
• MITnotableStrategic or Co-development PartnerAI tool development collaboration for nerve block anesthetics with USAISR
• Medical Technology Enterprise ConsortiumcoreStrategic or Co-development PartnerCollaboration to connect with brain health innovators and foster medical technology development
• NASAnotableStrategic or Co-development PartnerJoint presentations and collaboration at annual Spring Research Festival
• U.S. Coast GuardcoreStrategic or Co-development PartnerProbability of Survival Decision Aid (PSDA) developed for USCG, now mandated for USCG use during search and rescue operations
• United Kingdom Coast GuardnotableStrategic or Co-development PartnerAdoption of CoWEDA cold weather decision aid technology for UK Coast Guard operations
• Department of Homeland SecuritynotableStrategic or Co-development PartnerAdoption of cold weather ensemble decision aid technology for DHS operations
• Republic of Korea MilitarynotableStrategic or Co-development PartnerAnnual military health care meeting collaboration and security cooperation partnerships including Cobra Gold exercises
• African Military Partners (African Lion 2025)notableStrategic or Co-development PartnerUSAMRIID biosurveillance capabilities demonstration at African Lion 2025 exercises
• Israeli Defense ForcesnotableStrategic or Co-development PartnerCollaboration on wearable technology research and future military medical technology priorities

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Biomedical Advanced Research and Development Authority (BARDA): BARDA is the HHS counterpart agency responsible for developing and procuring medical countermeasures against CBRN threats, pandemic influenza, and emerging infectious diseases. Both organizations share a mission of translating early-stage biodefense research into FDA-approved products and operate as federal R&D funders rather than commercial entities.
• Defense Threat Reduction Agency (DTRA): DTRA is the DoD agency responsible for countering weapons of mass destruction, including biological threats. Its research and development portfolio directly overlaps with MIDRP's infectious disease and CBRN countermeasure work.
• Henry M. Jackson Foundation for the Advancement of Military Medicine: HJF is a nonprofit organization that provides scientific and administrative support to military medical research, including many intramural research programs at MRDC facilities. It collaborates closely with MIDRP laboratories and is functionally embedded in the same military medical research ecosystem.
• Naval Medical Research Center (NMRC): NMRC is the U.S. Navy's flagship infectious disease and biomedical research command, operating across multiple labs worldwide. Both are DoD medical research commands focused on infectious disease, operational medicine, and combat casualty care for their respective service branches.

Broad incumbents

• Air Force Research Laboratory (AFRL): AFRL is the Air Force's primary scientific research and development organization, including the 711th Human Performance Wing which conducts aeromedical and life sciences research. Both are military R&D commands with biomedical portfolios, though AFRL covers a much broader mission including aerospace systems.
• Centers for Disease Control and Prevention (CDC): CDC is the U.S. public health agency responsible for disease surveillance, outbreak response, and reference laboratory networks. Both organizations contribute to infectious disease preparedness, reference diagnostic capability, and pandemic response, though CDC serves civilian rather than military populations.
• Battelle Memorial Institute: Battelle is a nonprofit applied science and technology organization that manages and conducts federally funded research across national security, health, and energy domains. Both organizations operate large-scale federal research infrastructure, although Battelle is a contractor rather than a government entity.
• National Institute of Allergy and Infectious Diseases (NIAID): NIAID is the lead NIH institute for infectious disease and immunology research, with extensive vaccine and therapeutic countermeasure programs. Both organizations conduct large-scale infectious disease research with overlapping pathogen portfolios (Ebola, malaria, HIV) and complementary federal funding streams.
• Defense Advanced Research Projects Agency (DARPA): DARPA funds high-risk, high-reward research for the DoD, including the Biological Technologies Office which funds advanced infectious disease, neuroscience, and human performance research. Both organizations leverage federal R&D funding to advance military-relevant biomedical innovation.

Others

• Medical Technology Enterprise Consortium (MTEC): MTEC is a nonprofit consortium that partners with the U.S. Army Medical Research and Development Command to fund and manage medical technology development. It functions as a funding and contracting intermediary that bridges MIDRP's research output with commercial medical technology innovators.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/USAMRDC
• LinkedInlinkedin.com/company/defense-health-agency-research-and-development-medical-research-and-development-command
• Instagraminstagram.com/usamrdc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Military Infectious Diseases Research Program